A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2 A7 antibody, Alternative Names: CYP2A7 control peptide, CYP2A7 antibody Blocking Peptide, Anti-CYP2A7 Blocking Peptide, Cytochrome P450 Family 2 Subfamily A Polypeptide 7 Blocking Peptide, CPA7 Blocking Peptide, CPAD Blocking Peptide, CYP2A Blocking Peptide, CYPIIA7 Blocking Peptide, P450-IIA4 Blocking Peptide, CYP2A7, CYPA7-2, CYPA7 2, CYPA7-2 Blocking Peptide, CYPA7 2 Blocking Peptide
CYP2A7
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
CYP2A7
(Cytochrome P450, Family 2, Subfamily A, Polypeptide 7 (CYP2A7))
Synonyme
CPA7 Peptide, CPAD Peptide, CYP2A Peptide, CYPIIA7 Peptide, P450-IIA4 Peptide, cytochrome P450 family 2 subfamily A member 7 Peptide, CYP2A7 Peptide
Hintergrund
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids.